Junko Hiroki

2.0k total citations
15 papers, 1.7k citations indexed

About

Junko Hiroki is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Junko Hiroki has authored 15 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Junko Hiroki's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Nitric Oxide and Endothelin Effects (3 papers) and Cardiac Imaging and Diagnostics (3 papers). Junko Hiroki is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Nitric Oxide and Endothelin Effects (3 papers) and Cardiac Imaging and Diagnostics (3 papers). Junko Hiroki collaborates with scholars based in Japan and United States. Junko Hiroki's co-authors include Hiroaki Shimokawa, Akira Takeshita, Yasushi Mukai, Midoriko Higashi, Kozo Kaibuchi, Jianxin Sun, Masao Takemoto, James K. Liao, Toshihiro Ichiki and Keiko Morikawa and has published in prestigious journals such as Circulation, Circulation Research and The FASEB Journal.

In The Last Decade

Junko Hiroki

15 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junko Hiroki Japan 12 876 573 547 220 180 15 1.7k
Hans Michael Piper Germany 28 979 1.1× 783 1.4× 457 0.8× 172 0.8× 106 0.6× 55 2.0k
Hideharu Tomita Japan 17 520 0.6× 825 1.4× 436 0.8× 221 1.0× 148 0.8× 26 1.5k
Noriko Takahara Japan 15 781 0.9× 363 0.6× 512 0.9× 223 1.0× 99 0.6× 26 1.9k
Françoise Marotte France 23 800 0.9× 812 1.4× 457 0.8× 315 1.4× 98 0.5× 29 1.7k
Kotaro Numaguchi Japan 13 846 1.0× 447 0.8× 258 0.5× 133 0.6× 81 0.5× 22 1.5k
Pamela Harding United States 28 698 0.8× 614 1.1× 315 0.6× 144 0.7× 167 0.9× 62 1.8k
Barbara L. Storer United States 21 515 0.6× 542 0.9× 550 1.0× 138 0.6× 178 1.0× 31 1.6k
Tsuyoshi Morishita Japan 19 601 0.7× 438 0.8× 571 1.0× 150 0.7× 109 0.6× 40 1.4k
Xiaomang You Canada 19 491 0.6× 481 0.8× 369 0.7× 292 1.3× 188 1.0× 29 1.5k
Hema Viswambharan United Kingdom 16 592 0.7× 395 0.7× 631 1.2× 236 1.1× 87 0.5× 39 1.6k

Countries citing papers authored by Junko Hiroki

Since Specialization
Citations

This map shows the geographic impact of Junko Hiroki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Hiroki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Hiroki more than expected).

Fields of papers citing papers by Junko Hiroki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junko Hiroki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Hiroki. The network helps show where Junko Hiroki may publish in the future.

Co-authorship network of co-authors of Junko Hiroki

This figure shows the co-authorship network connecting the top 25 collaborators of Junko Hiroki. A scholar is included among the top collaborators of Junko Hiroki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Hiroki. Junko Hiroki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hiroki, Junko, Hiroaki Shimokawa, Midoriko Higashi, et al.. (2004). Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. Journal of Molecular and Cellular Cardiology. 37(2). 537–546. 133 indexed citations
2.
Oi, Keiji, Hiroaki Shimokawa, Junko Hiroki, et al.. (2004). Remnant Lipoproteins from Patients with Sudden Cardiac Death Enhance Coronary Vasospastic Activity Through Upregulation of Rho-Kinase. Arteriosclerosis Thrombosis and Vascular Biology. 24(5). 918–922. 50 indexed citations
3.
Hattori, Tsuyoshi, Hiroaki Shimokawa, Midoriko Higashi, et al.. (2004). Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling After Myocardial Infarction in Mice. Circulation. 109(18). 2234–2239. 191 indexed citations
4.
Hiroki, Junko, Hiroaki Shimokawa, Yasushi Mukai, Toshihiro Ichiki, & Akira Takeshita. (2004). Divergent effects of estrogen and nicotine on Rho-kinase expression in human coronary vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 326(1). 154–159. 61 indexed citations
5.
Hiroki, Junko, Yoshihiro Fukumoto, Hiroaki Shimokawa, Yoshitaka Hirooka, & Akira Takeshita. (2004). [Inhibition of Rho-kinase by fasudil preventing anginal attacks associated with spastic angina: a case report].. PubMed. 44(4). 161–4. 10 indexed citations
6.
Hiroki, Junko, Hiroaki Shimokawa, Midoriko Higashi, et al.. (2003). Inflammatory Stimuli Upregulate Rho-Kinase in Human Coronary Vascular Smooth Muscle Cells : Divergent Effects of Estrogen and Nicotine. Japanese Circulation Journal-english Edition. 67. 152. 1 indexed citations
7.
Mukai, Yasushi, Hiroaki Shimokawa, Tetsuya Matoba, et al.. (2003). Acute Vasodilator Effects of HMG-CoA Reductase Inhibitors: Involvement of P13-kinase/Akt Pathway and Kv Channels. Journal of Cardiovascular Pharmacology. 42(1). 118–123. 27 indexed citations
8.
Hattori, Tsuyoshi, Hiroaki Shimokawa, Midoriko Higashi, et al.. (2003). Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice. Circulation Research. 94(1). 46–52. 69 indexed citations
9.
Higashi, Midoriko, Hiroaki Shimokawa, Tsuyoshi Hattori, et al.. (2003). Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II–Induced Cardiovascular Hypertrophy in Rats In Vivo. Circulation Research. 93(8). 767–775. 353 indexed citations
10.
Hiroki, Junko, Hiroaki Shimokawa, Tadashi Kandabashi, et al.. (2002). Inflammatory stimuli upregulate Rho-kinase expression in human coronary vascular smooth muscle cells. Japanese Circulation Journal-english Edition. 66. 282. 1 indexed citations
11.
Takemoto, Masao, Jianxin Sun, Junko Hiroki, Hiroaki Shimokawa, & James K. Liao. (2002). Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase. Circulation. 106(1). 57–62. 395 indexed citations
12.
Mukai, Yasushi, Hiroaki Shimokawa, Midoriko Higashi, et al.. (2002). Inhibition of Renin-Angiotensin System Ameliorates Endothelial Dysfunction Associated With Aging in Rats. Arteriosclerosis Thrombosis and Vascular Biology. 22(9). 1445–1450. 83 indexed citations
13.
Mukai, Yasushi, Hiroaki Shimokawa, Tetsuya Matoba, et al.. (2001). Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. The FASEB Journal. 15(6). 1062–1064. 252 indexed citations
14.
Mukai, Yasushi, Hiroaki Shimokawa, Tetsuya Matoba, et al.. (2001). Involvement of Rho‐kinase in hypertensive vascular disease —a novel therapeutic target in hypertension. The FASEB Journal. 15(6). 1062–1064. 24 indexed citations
15.
Y, Eto, Hiroaki Shimokawa, Junko Hiroki, et al.. (2000). Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs. American Journal of Physiology-Heart and Circulatory Physiology. 278(6). H1744–H1750. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026